Category: Bioscience

Grants, hard work put polymer company on the international map

On one hand, Dr. Sumedh Surwade has worked long, lonely hours trying to prove that his environmentally friendly, anti-corrosive coating technology is both effective and marketable. But on the other hand, Surwade is quick to use the phrase “we” to describe the help he’s gotten to reach a point where he just won a prestigious…

In 1991, CB Research and Development was founded in a 2,000-square-foot facility to synthesize specialized chemical compounds for drug-makers. There were three employees. That same year, Incyte was founded in Palo Alto, California, to focus on genomics. After going public in 1993, the company added drug discovery to its business.  And, oh, how things have…

Delaware bioscience companies and boosters will showcase the state’s strength at the international BIO Convention in Philadelphia from June 3 to 6. The annual event is expected to draw 18,000 venture capitalists, scientists, researchers and startups from 70 countries. “Delaware has a uniquely expansive array of bioscience businesses,” said Helen Stimson, CEO and president of…

Wilmington PharmaTech has announced plans to open a $17 million research and manufacturing facility on 2309 Sunset Lake Road in Newark. The firm currently employs 37 workers in the U.S. and operates out of four smaller locations in New Castle County. Dr. Ke Li, director of operations at PharmaTech, today presented the company’s growth plans…

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), headquartered in Newark, Delaware, has released three technology “roadmaps” designed to benefit the biopharmaceutical community. These long-range plans focus on manufacturing issues involving: (1) Gene Therapy, (2) Vaccines, and (3) Antibody-Drug Conjugates (ADC) and Bi-specific Antibodies. NIIMBL brought together experts from leading biomanufacturers, equipment makers, suppliers,…

By Dan Metz Special to Delaware Business Times Helen Stimson is the president and CEO of Delaware BioScience Association, one of the host organizations of the 2019 BIO International Convention, which will take place in Philadelphia in June of 2019. Among the Delaware representatives, Dr. Eric Kmiec from Christiana Care has been chosen to chair…

Incyte Corporation announced today that it has been named one of the global biotechnology and pharmaceutical industry’s top employers by Science magazine, ranking second on the list of only 20 companies recognized in the publication’s annual Top Employer’s Survey. “We are proud to be recognized as the number two top employer in the biopharma industry…

Delaware Innovation Space embraces smaller startups

By Dan Linehan  Special to Delaware Business Times Like the emerging companies it cultivates, the Delaware Innovation Space has a growth timeline of its own. It started in March 2017 as an incubator guiding fledgling companies through their earliest stages. Like an egg incubator that controls heat and humidity to create an optimal environment to…

The steady rise of Prelude Therapeutics

By Dan Linehan Special to Delaware Business Times It’s natural to draw parallels between Kris Vaddi’s time discovering drugs at Incyte, where he spent 14 years, and his latest startup venture, Prelude Therapeutics. But there are many differences. At Incyte, Vaddi joined a thriving public company with hundreds of millions in cash and investments when…